|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 05011 | Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer. |
| 40986 | CPT-11 in combination with weekly 24h infusion 5-FU plus FA relative to weekly 24h infusion 5-FU plus FA alone in patients with advanced colorectal cancer |
| 40971 | Total Mesorectal Excision (TME) with or without pre-operative radiotherapy in the treatment of primary rectal cancer. |
| 05963 | First line infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for metastatic colo-rectal cancer or loco-regional recurrency. Role of chronomodulated delivery upon survival. A multicenter randomized Phase III trial. |
| 40952 | Randomized phase III study of weekly 24 h infusion of high-dose 5-FU with or without Folinic Acid Vs bolus 5-FU plus Folinic Acid in advanced colorectal cancer (Jointly with the Arbeitsgemeinschaft fr Internistische Onkologie - AIO) |
| 40911 | A phase III study of adjuvant regional and systemic chemotherapy in high risk resected colorectal cancers |
| 16871C | Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89) |
| 40872 | A randomized phase III study of low dose methotrexate (LD-MTX) plus high dose 5-Fluorouracil (HD-FU) versus HD-FU in advanced or metastatic colorectal carcinoma. |
| 40871 | A simple, large-scale randomized phase III trial on hepatic perfusion of 5-FU and heparin in resectable cancer of the colon and rectum |
| 22861 | Randomized phase II-III trial of radiotherapy alone or with concomitant chemotherapy in the treatment of anal carcinoma. (Jointly with the EORTC Radiotherapy Cooperative Group) |
| 16864D | Phase II Chemotherapy with Flavone Acetic Acid in Patients with Colorectal Cancer Who Have Received No Prior Chemotherapy (Summary Last Modified 03/88) |
| 04861 | Etude clinique phase II 4' -0-tetrahydropyranyl adriamycine (THP-ADM-1609 RB) |
| 16854D | Phase II trial of TCNU in non-pretreated patients with advanced colorectal cancer |
| 16841A | Phase II Chemotherapy with Menogaril in Patients with Advanced Colorectal Cancer |
| 22831 | Phase III trial for resectable rectal cancer using postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and the liver |
| 40983 | Pre-and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV versus Surgery alone in Resectable Liver Metastases from Colorectal Origin- Phase III Study |
| 22921 | Four arms phase III clinical trial for T3-T4 resectable rectal cancer comparing pre-operative pelvic irradiation to pre-operative irradiation combined with fluorouracil and Leucovorin with or without post-operative adjuvant chemotherapy |
| 40054 | Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaplatin vs.capecitabine alone in locally advanced rectal cancer (PETACC-6). |
| 16991C | Open lablel Phase II study on XR5000 administered as a 5 day infusion in advanced colorectal cancer:EORTC study 16991C |